Robertson Stephens Wealth Management, LLC
Position in SRPT — Sarepta Therapeutics, Inc.
CIK 1767307
San Francisco, CA
Position in SRPT
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$239,860
-$1,357 QoQ
Shares Held
11,023
-1.7% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Robertson Stephens Wealth Management, LLC holds $3,118,849 across 12 Biotechnology names. SRPT ranks #4 (7.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,836 | $938,347 | |
| 2 | MRNA |
Moderna, Inc.
|
14,855 | $754,634 | |
| 3 | INCY |
Incyte Corp
|
6,683 | $629,003 | |
| 4 | SRPT |
Sarepta Therapeutics, Inc.
This page
|
11,023 | $239,860 | |
| 5 | RLMD |
Relmada Therapeutics, Inc.
|
25,000 | $174,000 | |
| 6 | CUE |
Cue Biopharma, Inc.
|
478,500 | $110,055 | |
| 7 | ATAI |
AtaiBeckley Inc.
|
28,297 | $100,171 | |
| 8 | ACHV |
Achieve Life Sciences, Inc.
|
20,000 | $58,800 |
All Filings in SRPT
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $239,860 | 11,023 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $241,217 | 11,209 | Shares | Sole | 2026-02-02 | |
| No filing history on record for this holder in this stock. | ||||||